Alfuzosin Hydrochloride-BP/EP
CAS No: 81403-68-1 | IUPAC: N-(3-((4-amino-6,7-dimethoxy-2-quinazolinyl) methylamino) propyl) tetrahydro-2-furancarboxamide. | Therapeutic Use: Anti-BPH | Mol.formula: C19H28ClN5O4 | Mol.Weight: 425.91 g/mol | HSN CODE: 30049099
STRUCTURE
Product Details
- Description: White to off-white crystalline powder.
- Solubility: Freely soluble in water, sparingly soluble in alcohol.
- Melting Point: 240°C
- pH: 4.0-5.5
- Loss on Drying: NMT-2.0%
- Assay: NLT-99.0 %
- Storage Condition: Stored in a cool, dry and ventilated place
- Type of Packing: Export worthy packing
Description
Alfuzosin is used to treat the signs and symptoms of benign enlargement of the prostate (benign prostatic hyperplasia or BPH). Benign enlargement of the prostate is a problem that can occur in men as they get older. The prostate gland is located below the bladder. As the prostate gland enlarges, certain muscles in the gland may become tight and get in the way of the tube that drains urine from the bladder. This can cause problems with urinating, such as a need to urinate often, a weak stream when urinating, or a feeling of not being able to empty the bladder completely.